Evidence map›Paper›PMID 36583834›Full record

ArticleForensic toxicology2023

Δ

Shuso Takeda, Masayo Hirao-Suzuki, Hironori Aramaki, Kazuhito Watanabe

Abstract read
PubMed Publisher
In one paragraph

Article in Forensic toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shuso TakedaLaboratory of Molecular Life Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Sanzou 1, Gakuen-Cho, Fukuyama, Hiroshima, 729-0292, Japan. s.takeda@fukuyama-u.ac.jp.ORCID http://orcid.org/0000-0003-2193-1421
Masayo Hirao-SuzukiLaboratory of Xenobiotic Metabolism and Environmental Toxicology, Faculty of Pharmaceutical Sciences, Hiroshima International University, 5-1-1 Hiro-Koshingai, Kure, Hiroshima, 737-0112, Japan.
Hironori AramakiDepartment of Molecular Biology, Daiichi University of Pharmacy, 22-1 Tamagawa-Cho, Minami-Ku, Fukuoka, 815-8511, Japan.
Kazuhito WatanabeCenter for Supporting Pharmaceutical Education, Daiichi University of Pharmacy, 22-1 Tamagawa-Cho, Minami-Ku, Fukuoka, 815-8511, Japan.
Daiichi University of Pharmacy · JPHiroshima International University · JP

Funding

Cooperative Research Program of the Network Joint Research Center for Materials and Devices 20211327Cooperative Research Program of the Network Joint Research Center for Materials and Devices 20221077Japan Society for the Promotion of Science 16K08354Japan Society for the Promotion of Science 20790149Japan Society for the Promotion of Science 21K12261Japan Society for the Promotion of Science 22K15288
6 · The paper itself

Abstract

purposeThe effects of extended Δ

methodsMCF-7 cells were treated with Δ

resultsΔ

conclusionsΔ

Indexed as

Breast NeoplasmsCell MovementDronabinolEstrogensEstroneFemaleHumansMCF-7 CellsReceptors, EstrogenDronabinolEstrogensEstroneReceptors, EstrogenEstrogen receptorMCF-7 cellsMigrationΔ9-Tetrahydrocannabinol

Identifiers

PMID36583834
OpenAlexW4313303154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.